Lunardi, Claudio

Baricitinib restrains the immune dysregulation in patients with severe COVID-19

Bronte, V., Ugel, S., Tinazzi, E., Vella, A., De Sanctis, F., Canè, S., Batani, V., Trovato, R., Fiore, A., Petrova, V., et al. (2020) · Journal of Clinical Investigation

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 281

Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy

Gorlova, O., Martin, J.-E., Rueda, B., Koeleman, B. P. C., Ying, J., Teruel, M., Diaz-Gallo, L.-M., Broen, J. C., Vonk, M. C., Simeon, C. P., et al. (2011) · PLoS Genetics

Systemic Sclerosis and Related DiseasesGenetic Associations and Epidemiology

Cited by 231

Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study

Fraticelli, P., Gabrielli, B., Pomponio, G., Valentini, G., Bosello, S., Riboldi, P., Gerosa, M., Faggioli, P., Giacomelli, R., Del Papa, N., et al. (2014) · Arthritis Research & Therapy

Systemic Sclerosis and Related DiseasesPulmonary Hypertension Research and Treatments

Cited by 108

Double‐blind cross‐over trial of oral sodium cromoglycate in patients with irritable bowel syndrome due to food intolerance

LUNARDI, C., BAMBARA, L. M., BIASI, D., CORTINA, P., PEROLI, P., NICOLIS, F., FAVARI, F., & PACOR, M. L. (1991) · Clinical & Experimental Allergy

Gastrointestinal motility and disordersFood Allergy and Anaphylaxis Research

Cited by 72